• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型BRCA2相互作用蛋白LIMD1对食管癌细胞中BRCA2的中心体定位至关重要。

Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.

作者信息

Hou Xiaobin, Li Tinghui, Ren Zhipeng, Liu Yang

机构信息

Department of Thoracic Surgery, Chinese PLA General Hospital, Beijing, China.

出版信息

Oncol Res. 2016;24(4):247-53. doi: 10.3727/096504016X14652175055765.

DOI:10.3727/096504016X14652175055765
PMID:27656835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7838625/
Abstract

Mutation of breast cancer 2, early onset (BRCA2) has been identified as a vital risk factor for esophageal cancer (EC). To date, several proteins have been reported as BRCA2-interacting proteins and are associated with multiple biological processes. This study's aim was to identify a novel interactive protein of BRCA2 and to explore its functional roles in EC. A yeast two-hybrid screening was performed to identify a novel BRCA2-interacting protein. Glutathione-S-transferase (GST) pull-down analysis was performed to find out how the binding domain of BRCA2 interacts with LIM domains containing 1 (LIMD1). The interaction between LIMD1 and BRCA2 at the endogenous level was confirmed by using coimmunoprecipitation and immunobloting. Furthermore, two different sequences of short hairpin RNAs (shRNAs) against LIMD1 were transfected into the human EC cell line ECA109. Afterward, the effects of LIMD1 suppression on the centrosome localization of BRCA2 and cell division were analyzed using an immunofluorescence microscope. Results showed that LIMD1 was a novel BRCA2-interacting protein, and LIMD1 interacted with the conserved region of BRCA2 (amino acids 2,750-3,094) in vitro. Importantly, after interfering with the protein expression of LIMD1 in ECA109 cells, the centrosome localization of BRCA2 was significantly abolished and abnormal cell division was significantly increased. These results suggested that LIMD1 is a novel BRCA2-interacting protein and is involved in the centrosome localization of BRCA2 and suppression of LIMD1, causing abnormal cell division in EC cells.

摘要

乳腺癌2号基因(BRCA2)早期突变已被确定为食管癌(EC)的一个重要风险因素。迄今为止,已有几种蛋白质被报道为与BRCA2相互作用的蛋白质,并与多种生物学过程相关。本研究的目的是鉴定一种新的BRCA2相互作用蛋白,并探讨其在食管癌中的功能作用。通过酵母双杂交筛选来鉴定一种新的BRCA2相互作用蛋白。进行谷胱甘肽 - S - 转移酶(GST)下拉分析,以了解BRCA2的结合结构域如何与含1个LIM结构域的蛋白(LIMD1)相互作用。通过免疫共沉淀和免疫印迹在体内水平证实了LIMD1与BRCA2之间的相互作用。此外,将针对LIMD1的两种不同序列的短发夹RNA(shRNA)转染到人食管癌细胞系ECA109中。随后,使用免疫荧光显微镜分析LIMD1抑制对BRCA2中心体定位和细胞分裂的影响。结果表明,LIMD1是一种新的BRCA2相互作用蛋白,并且LIMD1在体外与BRCA2的保守区域(氨基酸2750 - 3094)相互作用。重要的是,干扰ECA109细胞中LIMD1的蛋白表达后,BRCA2的中心体定位明显消失,异常细胞分裂明显增加。这些结果表明,LIMD1是一种新的BRCA2相互作用蛋白,参与BRCA2的中心体定位,抑制LIMD1会导致食管癌细胞异常细胞分裂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/9f5dffd40aa1/OR-24-247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/3876693ef53e/OR-24-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/47a454e45661/OR-24-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/9f5dffd40aa1/OR-24-247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/3876693ef53e/OR-24-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/47a454e45661/OR-24-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0434/7838625/9f5dffd40aa1/OR-24-247-g003.jpg

相似文献

1
Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.新型BRCA2相互作用蛋白LIMD1对食管癌细胞中BRCA2的中心体定位至关重要。
Oncol Res. 2016;24(4):247-53. doi: 10.3727/096504016X14652175055765.
2
WTIP interacts with BRCA2 and is essential for BRCA2 centrosome localization in cervical cancer cell.WTIP与BRCA2相互作用,对BRCA2在宫颈癌细胞中的中心体定位至关重要。
Arch Gynecol Obstet. 2016 Nov;294(6):1311-1316. doi: 10.1007/s00404-016-4176-9. Epub 2016 Aug 18.
3
LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells.LIMD1 通过增强癌细胞中的 Rb 功能来拮抗 E2F1 活性和细胞周期进程。
Cell Biol Int. 2014 Jul;38(7):809-17. doi: 10.1002/cbin.10266. Epub 2014 Feb 27.
4
BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.BRCA2通过与胞质动力蛋白相互作用介导中心体黏附。
Cell Cycle. 2016 Aug 17;15(16):2145-2156. doi: 10.1080/15384101.2016.1195531. Epub 2016 Jul 19.
5
Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage.新型BRCA2相互作用蛋白BJ-HCC-20A可抑制因DNA损伤而引发的细胞凋亡。
Cancer Sci. 2008 Apr;99(4):747-54. doi: 10.1111/j.1349-7006.2008.00733.x. Epub 2008 Feb 27.
6
LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications.LIMD1 比 RB1 在头颈部鳞状细胞癌中更常发生改变:临床和预后意义。
Mol Cancer. 2010 Mar 12;9:58. doi: 10.1186/1476-4598-9-58.
7
LIMD1 phosphorylation in mitosis is required for mitotic progression and its tumor-suppressing activity.LIMD1 的磷酸化在有丝分裂中对于有丝分裂的进行及其肿瘤抑制活性是必需的。
FEBS J. 2019 Mar;286(5):963-974. doi: 10.1111/febs.14743. Epub 2019 Jan 16.
8
Over expression of HIF1α is associated with inactivation of both LimD1 and VHL in renal cell carcinoma: Clinical importance.缺氧诱导因子1α(HIF1α)的过表达与肾细胞癌中LimD1和VHL的失活相关:临床意义。
Pathol Res Pract. 2017 Dec;213(12):1477-1481. doi: 10.1016/j.prp.2017.10.009. Epub 2017 Oct 10.
9
BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization.BRCA2与细胞骨架连接蛋白网蛋白相互作用,形成一个控制中心体定位的复合物。
Cancer Sci. 2009 Nov;100(11):2115-25. doi: 10.1111/j.1349-7006.2009.01282.x. Epub 2009 Jul 8.
10
PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1.PU.1 是肿瘤抑制基因 LIMD1 的主要转录激活因子。
FEBS Lett. 2011 Apr 6;585(7):1089-96. doi: 10.1016/j.febslet.2011.03.013. Epub 2011 Mar 12.

引用本文的文献

1
Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.LIMD1基因沉默促进非霍奇金淋巴瘤的增殖并逆转细胞黏附介导的耐药性。
Oncol Lett. 2019 Mar;17(3):2993-3000. doi: 10.3892/ol.2019.9921. Epub 2019 Jan 11.
2
LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1.LIMD1是胃癌的一种生存预后标志物,通过抑制YAP1的激活来阻碍肿瘤进展。
Cancer Manag Res. 2018 Oct 9;10:4349-4361. doi: 10.2147/CMAR.S174856. eCollection 2018.
3
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.

本文引用的文献

1
UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo.UBE2D3基因过表达增强了EC109食管癌细胞在体内外的放射敏感性。
Oncotarget. 2016 May 31;7(22):32543-53. doi: 10.18632/oncotarget.8869.
2
Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma.术前白蛋白-球蛋白评分低预示食管鳞状细胞癌患者生存良好。
Oncotarget. 2016 May 24;7(21):30550-60. doi: 10.18632/oncotarget.8868.
3
Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients.
缺氧诱导因子-LIMD1 负反馈机制减轻了缺氧的促肿瘤效应。
EMBO Mol Med. 2018 Aug;10(8). doi: 10.15252/emmm.201708304.
4
Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.在头颈部肿瘤发生过程中,正常上皮的基底层/副基底层与棘层之间 RBSP3、LIMD1 和 CDC25A 分子特征的差异传递:一项机制研究。
PLoS One. 2018 Apr 19;13(4):e0195937. doi: 10.1371/journal.pone.0195937. eCollection 2018.
内镜下肿瘤长度应重新纳入食管癌分期系统:对662例连续患者的分析
PLoS One. 2016 Apr 18;11(4):e0153068. doi: 10.1371/journal.pone.0153068. eCollection 2016.
4
Improving Outcomes for Esophageal Cancer using Proton Beam Therapy.使用质子束疗法改善食管癌治疗效果。
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):488-497. doi: 10.1016/j.ijrobp.2015.11.043. Epub 2015 Dec 14.
5
Thrombospondin-4 reduces binding affinity of [(3)H]-gabapentin to calcium-channel α2δ-1-subunit but does not interact with α2δ-1 on the cell-surface when co-expressed.血小板反应蛋白-4降低了[³H]-加巴喷丁与钙通道α2δ-1亚基的结合亲和力,但共表达时不与细胞表面的α2δ-1相互作用。
Sci Rep. 2016 Apr 14;6:24531. doi: 10.1038/srep24531.
6
The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.食管癌患者血清趋化因子CXCL12及其特异性受体CXCR4的浓度
Dis Markers. 2016;2016:7963895. doi: 10.1155/2016/7963895. Epub 2016 Mar 3.
7
Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.同源转录因子DUX4和DUX4c在肌肉分化过程中与细胞质蛋白相关联。
PLoS One. 2016 Jan 27;11(1):e0146893. doi: 10.1371/journal.pone.0146893. eCollection 2016.
8
Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.半乳糖凝集素-3的基因沉默改变了Eca109人食管癌细胞的生物学行为。
Mol Med Rep. 2016 Jan;13(1):160-6. doi: 10.3892/mmr.2015.4543. Epub 2015 Nov 10.
9
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.食管癌:东西方国家的风险因素、筛查及内镜治疗
World J Gastroenterol. 2015 Jul 14;21(26):7933-43. doi: 10.3748/wjg.v21.i26.7933.
10
CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells.CD44通过调节人类乳腺癌细胞中的c-Src转录来调控细胞增殖、迁移和侵袭。
Cell Signal. 2015 Sep;27(9):1882-94. doi: 10.1016/j.cellsig.2015.05.002. Epub 2015 May 12.